James Robinson Speciality Ingredients (JRSI) has launched a dedicated 186 m2 biotechnology R&D facility called the Biotome division in Manchester. The company is seeking to focus more on naturally derived products for the personal care market.
This follows a management buyout of the James Robinson heritage brand for the part making ingredients for personal care and photochromics in 2019. The original firm had been based in Huddersfield since 1940 until being acquired by India’s Vivimed Labs in 2008.
